Mutations in MAGEL2 and L1CAM Are Associated With Congenital Hypopituitarism and Arthrogryposis.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 12 2019
Historique:
received: 18 03 2019
accepted: 18 07 2019
pubmed: 11 9 2019
medline: 5 6 2020
entrez: 11 9 2019
Statut: ppublish

Résumé

Congenital hypopituitarism (CH) is rarely observed in combination with severe joint contractures (arthrogryposis). Schaaf-Yang syndrome (SHFYNG) phenotypically overlaps with Prader-Willi syndrome, with patients also manifesting arthrogryposis. L1 syndrome, a group of X-linked disorders that include hydrocephalus and lower limb spasticity, also rarely presents with arthrogryposis. We investigated the molecular basis underlying the combination of CH and arthrogryposis in five patients. The heterozygous p.Q666fs*47 mutation in the maternally imprinted MAGEL2 gene, previously described in multiple patients with SHFYNG, was identified in patients 1 to 4, all of whom manifested growth hormone deficiency and variable SHFYNG features, including dysmorphism, developmental delay, sleep apnea, and visual problems. Nonidentical twins (patients 2 and 3) had diabetes insipidus and macrocephaly, and patient 4 presented with ACTH insufficiency. The hemizygous L1CAM variant p.G452R, previously implicated in patients with L1 syndrome, was identified in patient 5, who presented with antenatal hydrocephalus. Human embryonic expression analysis revealed MAGEL2 transcripts in the developing hypothalamus and ventral diencephalon at Carnegie stages (CSs) 19, 20, and 23 and in the Rathke pouch at CS20 and CS23. L1CAM was expressed in the developing hypothalamus, ventral diencephalon, and hindbrain (CS19, CS20, CS23), but not in the Rathke pouch. We report MAGEL2 and L1CAM mutations in four pedigrees with variable CH and arthrogryposis. Patients presenting early in life with this combined phenotype should be examined for features of SHFYNG and/or L1 syndrome. This study highlights the association of hypothalamo-pituitary disease with MAGEL2 and L1CAM mutations.

Identifiants

pubmed: 31504653
pii: 5537539
doi: 10.1210/jc.2019-00631
pmc: PMC6916815
doi:

Substances chimiques

L1CAM protein, human 0
MAGEL2 protein, human 0
Neural Cell Adhesion Molecule L1 0
Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5737-5750

Subventions

Organisme : Medical Research Council
ID : MR/R006237/1
Pays : United Kingdom
Organisme : MRF
ID : MRF_MRF-099-0002-RG-UCLIC
Pays : United Kingdom

Informations de copyright

Copyright © 2019 Endocrine Society.

Références

Sci Transl Med. 2014 Dec 3;6(265):265ra168
pubmed: 25473036
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7753-7
pubmed: 3478724
J Neurosci. 1995 Jan;15(1 Pt 1):419-28
pubmed: 7823146
Brain Res Dev Brain Res. 2001 Jan 31;126(1):21-30
pubmed: 11172883
Physiol Genomics. 2007 Jul 18;30(2):156-71
pubmed: 17374844
Am J Hum Genet. 2015 Oct 1;97(4):616-20
pubmed: 26365340
Nat Genet. 1994 Jul;7(3):402-7
pubmed: 7920659
EMBO J. 1999 Sep 1;18(17):4744-53
pubmed: 10469653
Hum Mol Genet. 2000 Jul 22;9(12):1813-9
pubmed: 10915770
J Med Genet. 2018 May;55(5):316-321
pubmed: 29599419
EMBO J. 1996 Nov 15;15(22):6050-9
pubmed: 8947027
Int J Endocrinol Metab. 2018 Jul 01;16(3):e67329
pubmed: 30323850
Hum Mol Genet. 2016 Sep 1;25(17):3798-3809
pubmed: 27436578
Proc Natl Acad Sci U S A. 1985 Feb;82(4):1276-80
pubmed: 3856258
Am J Med Genet A. 2018 Mar;176(3):707-711
pubmed: 29359444
J Neurosurg. 2006 Nov;105(5 Suppl):403-12
pubmed: 17328266
Curr Biol. 1998 Jan 1;8(1):26-33
pubmed: 9427628
Mol Cell. 2010 Sep 24;39(6):963-74
pubmed: 20864041
Hum Mutat. 2013 Dec;34(12):1721-6
pubmed: 24123792
JIMD Rep. 2016;27:79-84
pubmed: 26446091
Am J Med Genet A. 2018 Nov;176(11):2456-2459
pubmed: 30238631
Nat Genet. 2008 Jun;40(6):719-21
pubmed: 18500341
J Med Genet. 1997 Aug;34(8):670-1
pubmed: 9279760
Hum Mol Genet. 2018 Sep 15;27(18):3129-3136
pubmed: 29878108
Neuropediatrics. 2000 Dec;31(6):325-7
pubmed: 11508555
Curr Biol. 2006 Jan 10;16(1):12-23
pubmed: 16401420
Hum Mol Genet. 2009 Sep 1;18(17):3257-65
pubmed: 19498035
Biochem J. 2017 Jun 16;474(13):2177-2190
pubmed: 28626083
Diseases. 2016 Jan 13;4(1):null
pubmed: 28933382
Genet Med. 2017 Jan;19(1):45-52
pubmed: 27195816
Ann Pediatr (Paris). 1993 Jun;40(6):376-8
pubmed: 8352501
Neurobiol Dis. 2019 Jan;121:58-64
pubmed: 30240706
Clin Genet. 1994 Apr;45(4):181-5
pubmed: 8062435
Nat Genet. 1997 Nov;17(3):346-9
pubmed: 9354804
J Comp Neurol. 2003 Dec 15;467(3):375-88
pubmed: 14608600
Brain Res. 2001 Feb 9;891(1-2):247-52
pubmed: 11164829
J Cell Biol. 1988 May;106(5):1735-46
pubmed: 2453520
Neurosci Res. 2004 Apr;48(4):471-5
pubmed: 15041201
Eur J Hum Genet. 2010 Nov;18(11):1196-201
pubmed: 20588305
PLoS One. 2009;4(1):e4291
pubmed: 19172181
Dev Dyn. 2003 Nov;228(3):475-9
pubmed: 14579385
Genes Brain Behav. 2017 Jul;16(6):592-600
pubmed: 28296079
Neuron Glia Biol. 2004 Feb;1(1):65-72
pubmed: 18634607
Pediatrics. 1993 Feb;91(2):398-402
pubmed: 8424017
Endocrinology. 2011 Mar;152(3):967-78
pubmed: 21248145
Cereb Cortex. 2004 Feb;14(2):121-31
pubmed: 14704209
Nat Genet. 2013 Nov;45(11):1405-8
pubmed: 24076603
J Comp Neurol. 2010 Apr 1;518(7):1113-32
pubmed: 20127821
J Cell Biol. 1986 Dec;103(6 Pt 1):2439-48
pubmed: 2430983
Am J Med Genet A. 2018 Dec;176(12):2564-2574
pubmed: 30302899
Am J Med Genet. 1990 Sep;37(1):65-70
pubmed: 2240046
Hum Mol Genet. 2007 Nov 15;16(22):2713-9
pubmed: 17728320

Auteurs

Louise C Gregory (LC)

Genetics and Genomic Medicine Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Pratik Shah (P)

Great Ormond Street Hospital, London, United Kingdom.

Juliane R F Sanner (JRF)

Great Ormond Street Hospital, London, United Kingdom.

Monica Arancibia (M)

Division de Pediatria, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.

Jane Hurst (J)

NE Thames Genetics Service, Great Ormond Street Hospital, London, United Kingdom.

Wendy D Jones (WD)

NE Thames Genetics Service, Great Ormond Street Hospital, London, United Kingdom.

Helen Spoudeas (H)

Great Ormond Street Hospital, London, United Kingdom.

Polona Le Quesne Stabej (P)

Genetics and Genomic Medicine Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Hywel J Williams (HJ)

Genetics and Genomic Medicine Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Louise A Ocaka (LA)

Genetics and Genomic Medicine Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Carolina Loureiro (C)

Division de Pediatria, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.

Alejandro Martinez-Aguayo (A)

Division de Pediatria, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.

Mehul T Dattani (MT)

Genetics and Genomic Medicine Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Great Ormond Street Hospital, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH